Cladribine Added to Idarubicin and Cytarabine as an Induction Regimen for Patients with <i>De Novo</i> Acute Myeloid Leukemia: A Multicenter, Randomized Phase III Trial

Cladribine added to the IA regimen was safe and effective in de novo AML. Patients with adverse risk or those between 45 and 60 years of age might benefit significantly on both response and survival with the IAC regimen.

Authors

Institutions

Publication Details

Journal
Clinical Cancer Research
Published
2025-02-26
DOI
https://doi.org/10.1158/1078-0432.ccr-24-2437
Primary Topic
Acute Myeloid Leukemia Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cladribine Added to Idarubicin and Cytarabine as an Induction Regimen for Patients with De Novo Acute Myeloid Leukemia: A Multicenter, Randomized Phase III Trial

Miao Miao, Myat Min Han, Suning Chen, Shengli Xue et al.
Clinical Cancer Research
Acute Myeloid Leukemia Research
article

Cladribine Added to Idarubicin and Cytarabine as an Induction Regimen for Patients with De Novo Acute Myeloid Leukemia: A Multicenter, Randomized Phase III Trial

Miao Miao, Myat Min Han, Suning Chen, Shengli Xue, Xiaowen Tang, Lian Bai, Chengcheng Fu, Zhengming Jin, Caixia Li, Haohao Han, Xiang Zhang, Ying Wang, Jia Chen, Depei Wu, Yue Han, Huiying Qiu, Aining Sun, Jun Chen, Zhihong Lin
article en

Abstract

Cladribine added to the IA regimen was safe and effective in de novo AML. Patients with adverse risk or those between 45 and 60 years of age might benefit significantly on both response and survival with the IAC regimen.

Clinical Cancer ResearchVol. 31(8)
Soochow University (CN), Suzhou Guangji Hospital (CN), Zhejiang Provincial People's Hospital (CN), Suzhou Traditional Chinese Medicine Hospital (CN), First Affiliated Hospital of Soochow University (CN), The Fifth People’s Hospital of Suzhou (CN)
National Natural Science Foundation of China, Priority Academic Program Development of Jiangsu Higher Education Institutions, Jiangsu Provincial Medical Center, Science and Technology Program of Suzhou
Good health and well-being
Openalex Percentile: Top 95%
Acute Myeloid Leukemia Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.